Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma Invasive Mucinous Pattern and Extracellular Mucin Are Associated With KRAS Mutation

被引:136
作者
Kadota, Kyuichi [1 ,3 ,6 ]
Yeh, Yi-Chen [1 ]
D'Angelo, Sandra P. [2 ]
Moreira, Andre L. [3 ]
Kuk, Deborah [4 ]
Sima, Camelia S. [4 ]
Riely, Gregory J. [2 ]
Arcila, Maria E. [3 ]
Kris, Mark G. [2 ]
Rusch, Valerie W. [1 ]
Adusumilli, Prasad S. [1 ,5 ]
Travis, William D. [3 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Thorac Serv, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, Div Solid Tumor Oncol, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA
[5] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10065 USA
[6] Kagawa Univ, Fac Med, Dept Diagnost Pathol, Takamatsu, Kagawa 760, Japan
关键词
lung; adenocarcinoma; subtype; mutation; mucin; GROWTH-FACTOR RECEPTOR; BRONCHIOLOALVEOLAR PATHOLOGICAL SUBTYPE; ATYPICAL ADENOMATOUS HYPERPLASIA; EGFR MUTATIONS; GENE-MUTATIONS; CLINICOPATHOLOGICAL FEATURES; INTERNATIONAL-ASSOCIATION; ROUTINE-PRACTICE; GRADING SYSTEM; BRAF MUTATIONS;
D O I
10.1097/PAS.0000000000000246
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Multiple reports indicate that epidermal growth factor receptor (EGFR) mutations are associated with lepidic-pattern lung adenocarcinoma and that KRAS mutations are associated with invasive mucinous adenocarcinoma. We sought to investigate the association between EGFR and KRAS mutations and specific morphologic characteristics, such as predominant histologic subtype and mucinous features. Clinical data for 864 patients with resected lung adenocarcinoma that underwent molecular testing for EGFR and KRAS mutations were collected. Histologic subtyping was performed according to the IASLC/ATS/ERS lung adenocarcinoma classification, with attention given to signet-ring cell feature and extracellular mucin. EGFR mutations were detected using a polymerase chain reaction-based sizing assay, KRAS mutations were detected using Sanger sequencing, and ALK expression was detected using immunohistochemistry. Invasive mucinous adenocarcinoma was associated with KRAS mutation (P<0.001). Among invasive mucinous adenocarcinomas with KRAS mutation, a pure mucinous pattern was more common than a mixed mucinous/nonmucinous pattern (P=0.002). Invasive mucinous adenocarcinoma was associated with KRAS transition mutations (G -> A) but not transversion mutations (G -> T or G -> C) compared with nonmucinous tumors (P=0.009). The lepidic-predominant group was associated with EGFR mutation compared with nonlepidic-predominant tumors (P=0.011). Extracellular mucin was associated with KRAS mutation (P<0.001), whereas signet-ring cell feature was not associated with EGFR or KRAS mutation (P=0.517). ALK expression was associated with signet-ring cell feature (P=0.001) but not with extracellular mucin (P=0.089). Our study shows that histologic patterns of mucin in lung adenocarcinoma-including invasive mucinous adenocarcinoma and extracellular mucin-are associated with KRAS mutation.
引用
收藏
页码:1118 / 1127
页数:10
相关论文
共 59 条
  • [41] Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma
    Riely, Gregory J.
    Kris, Mark G.
    Rosenbaum, Daniel
    Marks, Jenifer
    Li, Allan
    Chitale, Dhananjay A.
    Nafa, Khedoudja
    Riedel, Elyn R.
    Su, Meier H.
    Pao, William
    Miller, Vincent A.
    Ladanyi, Marc
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (18) : 5731 - 5734
  • [42] Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC
  • [43] Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population
    Rodig, Scott J.
    Mino-Kenudson, Mari
    Dacic, Sanja
    Yeap, Beow Y.
    Shaw, Alice
    Barletta, Justine A.
    Stubbs, Hannah
    Law, Kenny
    Lindeman, Neal
    Mark, Eugene
    Janne, Pasi A.
    Lynch, Thomas
    Johnson, Bruce E.
    Iafrate, A. John
    Chirieac, Lucian R.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5216 - 5223
  • [44] Rusch VW., 2009, AJCC CANC STAGING MA, V7, P253
  • [45] Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients
    Russell, Prudence A.
    Barnett, Stephen A.
    Walkiewicz, Marzena
    Wainer, Zoe
    Conron, Matthew
    Wright, Gavin M.
    Gooi, Julian
    Knight, Simon
    Wynne, Rochelle
    Liew, Danny
    John, Thomas
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (04) : 461 - 468
  • [46] Does Lung Adenocarcinoma Subtype Predict Patient Survival? A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification
    Russell, Prudence A.
    Wainer, Zoe
    Wright, Gavin M.
    Daniels, Marissa
    Conron, Matthew
    Williams, Richard A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) : 1496 - 1504
  • [47] Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas
    Sakamoto, H.
    Shimizu, J.
    Horio, Y.
    Ueda, R.
    Takahashi, T.
    Mitsudomi, T.
    Yatabe, Y.
    [J]. JOURNAL OF PATHOLOGY, 2007, 212 (03) : 287 - 294
  • [48] Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Who Harbor EML4-ALK
    Shaw, Alice T.
    Yeap, Beow Y.
    Mino-Kenudson, Mari
    Digumarthy, Subba R.
    Costa, Daniel B.
    Heist, Rebecca S.
    Solomon, Benjamin
    Stubbs, Hannah
    Admane, Sonal
    McDermott, Ultan
    Settleman, Jeffrey
    Kobayashi, Susumu
    Mark, Eugene J.
    Rodig, Scott J.
    Chirieac, Lucian R.
    Kwak, Eunice L.
    Lynch, Thomas J.
    Iafrate, A. John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4247 - 4253
  • [49] Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
    Shigematsu, H
    Lin, L
    Takahashi, T
    Nomura, M
    Suzuki, M
    Wistuba, II
    Fong, KM
    Lee, H
    Toyooka, S
    Shimizu, N
    Fujisawa, T
    Feng, ZD
    Roth, JA
    Herz, J
    Minna, JD
    Gazdar, AF
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (05): : 339 - 346
  • [50] Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features
    Tam, IYS
    Chung, LP
    Suen, WS
    Wang, E
    Wong, MCM
    Ho, KK
    Lam, WK
    Chiu, SW
    Girard, L
    Minna, JD
    Gazdar, AF
    Wong, MP
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (05) : 1647 - 1653